In this recent interview with DPHARM: Disruptive Innovations to Modernize Clinical Research, our CTO Sean Connolly shared insights on scaling technology adoption in large pharma. "You need to think systematically, and break down big problems into its component parts, because that allows you to deliver value iteratively as you work to achieve scale." You can read the full interview here https://lnkd.in/eAJvKxRb
About us
Digital solutions need to do more to propel clinical development, elevate user experiences and accelerate better health outcomes. At Evinova, we’re doing something about it. We’re a healthtech business, with globally-scaled digital products that have proven benefits for sponsors, sites and patients. We've accelerated timelines, improved patient experiences, reduced costs, and minimised carbon footprints across hundreds of clinical studies. Evinova is a 300 person strong team offering digital solutions to pharma, biotech and CROs to support clinical research globally. Community Guidelines: http://bit.ly/3JIeErQ
- Website
-
https://evinova.com/
External link for Evinova
- Industry
- Software Development
- Company size
- 201-500 employees
- Type
- Public Company
- Founded
- 2023
- Specialties
- Pharmaceutical, Biopharmaceutical, Innovation, Technology solutions, Global business, and Healthtech
Employees at Evinova
-
Simon Pulman-Jones
Head of Design, Patient Solutions @ Evinova, an AstraZeneca Healthtech Business
-
John Mercer
Leading ML/AI Operations @ Evinova, an AstraZeneca Healthtech business
-
Ferran Foz Pedemonte
Digital Health | Global Digital Lead | Omnichannel Marketing Manager
-
Thomas Sutton
Chief Design Officer at Evinova
Updates
-
Meet the Evinova team at SCOPE Europe in Barcelona today and tomorrow. If you’re around, look out for us —we’d love to connect! #SCOPEsummit
-
Are you attending #HLTH in Las Vegas? Make sure to look out for our #Evinova team! Cristina Ortega Duran Gillian Livock MBA James Thatcher Camila Matheny and Gabriela Feldberg
-
Meet us at GlobalLink NEXT Europe in London on October 15-16! Our team will be showcasing exciting developments at these sessions: 🔹 Removing barriers one language at a time: A look inside Unified Trial Solution - Amanda Thoniati fcMgr CMI 🔹 Panel discussion: Digital health - Avenues for health equity - Pau Almuni We look forward to connecting and sharing our latest insights on the future of digital health and trial solutions. #GlobalLinkNEXT
-
Connect with us at International Society for Quality of Life Research 31st Annual Conference in Cologne, Germany from October 13-16! Our team will be presenting at these key events: 🔹ISOQOL posters - Ciara Dwan, ACMA, Cara Arizmendi 🔹ISOQOL workshops - Haylee Anders and Sally Mannix 🔹ISOQOL Statistics special interest group symposium - Lysbeth Floden We look forward to seeing you there! #ISOQOL
-
We're presenting at Digital Health & AI Innovation Summit (DHAI) Our Senior Director Lauren Bataille will be speaking at DHAI on 'Re-imagining Clinical Trial Design in Heart Failure.' 📅 October 7-9 📍 Boston Marriott Cambridge, Massachusetts We are looking forward to connecting with you soon. Want to schedule a meeting with our team ahead of the event? Send us a message through LinkedIn, and we’ll arrange a time. #dhai2024 #digitalhealth
-
Join us at Arena International Events Group's Nordics 2024 Outsourcing in Clinical Trials Event Series for our presentation on "Accelerating Innovation Through Digital Health Technology Solutions" by Magnus Jörntén-Karlsson 🗓 October 2 📍Denmark We look forward to connecting with you at the event. If you’d like to schedule a meeting, please reach out to us directly via LinkedIn Messenger.
-
🚨We’re excited to announce that during the International Society for Quality of Life Research annual meeting (ISOQOL), Evinova’s Head of Digital Science Products, Madalina L. Sucala, PhD, MBA, will be presenting: "Amplifying the Patient’s Voice: Using Patient-Reported Data to Inform Remote Monitoring by Healthcare Providers for Improved Treatment Outcomes." Co-authored by: Sally Mannix, Lucie Miller-Potucka, Simon Pulman-Jones, Alicyn Campbell, Elisabeth Piault-Louis. We look forward to connecting with you at the event! If you'd like to schedule a meeting with our team, feel free to reach out via Evinova's LinkedIn messenger. See you in Cologne, Germany 🇩🇪 #ISOQOL
-
📣 We are excited to announce the appointment of Jill Bell as Evinova's Chief Science Officer. Jill brings a wealth of experience and expertise in the design, management, and analysis of quality of life and other patient-reported outcomes (PRO) projects at Evinova, AstraZeneca, and Takeda. Jill's strategic vision and leadership in developing and validating PRO measures across a range of therapeutic areas will steer our continued development of science-based solutions to solve the industry's biggest challenges. ⭐ "Our North Star is to provide the right data, at the right time, with the right analytics and the right insights to deliver better patient care." - Jill Bell, Chief Science Officer at Evinova.
-
We're speaking at DPHARM: Disruptive Innovations to Modernize Clinical Research 🎤 Evinova's CGO, Gillian Livock MBA, will join industry experts including Felix Lee, Katie Madden PMP and Rob Wilson at #DHARM2024 to discuss 'Disrupting the Evidence Generation Paradigm: Driving Greater Adoption of DHTs and Endpoints in Clinical Trials.' 🗓️ 17-18th September 📍 Philadelphia Schedule a meeting with Gill to connect at the event through Evinova's LinkedIn messenger.